Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model

[1] Brabletz T(2013)Roadblocks to translational advances on metastasis research Nat Med 19 1104-1109

[2] Lyden D(2018)Cancer statistics 2018 CA Cancer J Clin 68 7-30

[3] Steeg PS(2012)Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis Cancer Metastasis Rev 31 397-414

[4] Werb Z(2013)Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study Pancreas 42 72-75

[5] Siegel RL(2019)Cancer stem cells: the architects of the tumor ecosystem Cell Stem Cell 24 41-53

[6] Miller KD(2017)Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 313-323

[7] Jemal A(2019)Targeting cancer stemness in the clinic: from hype to hope Cell Stem Cell 24 25-40

[8] Sodek KL(2017)Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting BMB Rep 50 117-125

[9] Murphy KJ(2014)DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a ‘common receptor coordinator’ paradigm PLoS One 9 e85821-313

[10] Brown TJ(2015)Endothelin-1 and endothelin B receptor expression in pancreatic adenocarcinoma J Clin Pathol 68 309-539

[1] Brabletz T(2013)Roadblocks to translational advances on metastasis research Nat Med 19 1104-1109

[2] Lyden D(2018)Cancer statistics 2018 CA Cancer J Clin 68 7-30

[3] Steeg PS(2012)Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis Cancer Metastasis Rev 31 397-414

[4] Werb Z(2013)Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study Pancreas 42 72-75

[5] Siegel RL(2019)Cancer stem cells: the architects of the tumor ecosystem Cell Stem Cell 24 41-53

[6] Miller KD(2017)Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 313-323

[7] Jemal A(2019)Targeting cancer stemness in the clinic: from hype to hope Cell Stem Cell 24 25-40

[8] Sodek KL(2017)Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting BMB Rep 50 117-125

[9] Murphy KJ(2014)DEspR roles in tumor vasculo-angiogenesis, invasiveness, CSC-survival and anoikis resistance: a ‘common receptor coordinator’ paradigm PLoS One 9 e85821-313

[10] Brown TJ(2015)Endothelin-1 and endothelin B receptor expression in pancreatic adenocarcinoma J Clin Pathol 68 309-539